China Pharma Holdings now says its Q3 results “could” show a positive cash flow. Last week, the company reported it expects a 40% increase in revenue during the period. China Pharma is doing well in terms of growth and profitability, but as we have reported over the past year, its growing Accounts Receivable numbers have kept the company from truly prospering. Now, China Pharma has released a statement that says new collection policies are starting to have a positive effect. More details...

Stock Symbol: (OTCBB: CPHI)